About Mito LuiXiaPharma
Mito LiuXia Pharma’s mission is to research and develop pharmaceutical and nutraceutical therapeutics to increase ATP production to restore damaged Mitochondrial function, promote quality of life, and strive toward excellent health. Our is to correct Mitochondrial Dysfunction and reverse aging.
Mitochondria’s most important function is essential energy production for supporting organ function and sustaining life. A lack of energy affects high energy demand organs first such as the brain and digestive organs. Nerves, muscles, and even skin, can also be affected. Clinical presentations generally include the following conditions as affected by, or causally related to, Mitochondrial Dysfunction: diabetes, cancer, cardio diseases, thyroid dysfunction, skin aging, recurrent infections, and neurodegenerative diseases (ex. Parkinson’s Disease, Alzheimer’s). It has long been proposed that these diseases could be effectively treated, even prevented, by correcting Mitochondrial Dysfunction.
Mito LiuXia Pharma has developed a new generation, proprietary Organic Redox Cofactor. Together, current research and clinical experience has achieved a redox cofactor that has yielded a positive outcome in the treatment and prevent of degenerative diseases and conditions.
The Organic Redox Cofactor is a lead compound that embodies the therapeutic strategy of “correcting” or modulating ATP-related mitochondrial functions. The company expects this unique innovation to have a major impact on developing new, novel therapeutics of both pharmaceutical and nutraceutical.
Long Island High-Technology Incubator of Stony Brook University
25 Health Science Drive
Mail Box: 410
Stony Brook NY 11790
Phone: (631) 292-9008
Fax: (631) 621-0259
© Mito Liuxa Pharma all rights reserved